FOR PREVIEWING & TESTING PURPOSES ONLY.
This notification will disappear once the page will be published.
This link is available for less than 30 minutes.
  • Easy to read
  • Text size
European Ombudsman
European Ombudsman

You have a complaint against an EU institution or body?

Make a complaint
Make a complaint
Current language: 
  • English
Available languages: 

Refusal by EMA to disclose the identity of the pharmaceutical company which made a request for public access to the latest periodic safety update reports on Zyclara, a drug to treat actinic keratosis

Case opened
Case 2030/2015/PL - Opened on Thursday | 03 March 2016 - Recommendation on Friday | 07 July 2017 - Decision on Tuesday | 20 March 2018 - Institution concerned European Medicines Agency ( Recommendation agreed by the institution ) - Country Germany

Allegation(s)

EMA wrongly refused to grant access to the identity of the pharmaceutical company which on 23 September 2015 made a request for public access to the periodic safety update reports (PSURs) on Zyclara produced by the complainant.

Claim(s)

EMA should grant the complainant access to the identity of the pharmaceutical company.